GRPR and neoplasm: For [111In]In-DOTA-PEG2-RM26, significant (p < 0.05) reduction of uptake for lung, pancreas, stomach, small intestine and tumour in the blocked group compared to non-blocked group was observed, indicating GRPR-specific accumulation of both radioconjugates.